South Korea Strengthens Patient Rights in Hospitalization Reviews, Addresses Trauma Concerns

Recent revisions to South Korea’s hospitalization suitability review regulations aim to bolster patient rights and address concerns highlighted by personal accounts of trauma experienced during involuntary hospitalizations. The changes, announced by the Ministry of Health and Welfare (MOHW) on February 22, 2026, approach as the number of involuntary hospitalizations continues to be significant, exceeding 180,000 cases over the past six years.

Guaranteeing Patient Voice

The most significant update officially guarantees patients the right to express their opinions during hospitalization suitability review processes. Previously, patients had limited opportunities to challenge the appropriateness of their hospitalization. Under the revised regulations, patients can now directly present their views to the review subcommittee.

Rising Hospitalization Rates and Scrutiny

Data from the National Mental Health Center reveals a total of 186,525 hospitalizations of non-mentally ill patients occurred between 2019, and 2024. In 2024 alone, 30,458 cases were reported, with approximately 9% of patients hospitalized for over a year. While face-to-face investigations in these cases have increased from 26.4% in 2019 to 44.1% in 2024, the discharge rate following an unfavorable review remains below 2%.

Addressing Trauma: The Case of Hyun Jun-hee

The regulatory changes arrive amidst growing awareness of the psychological impact of involuntary hospitalization. Hyun Jun-hee, the son of former professional basketball player Hyun Joo-yeop, recently shared his traumatic experiences with psychiatric ward stays on TV Chosun’s “Dad and Me.” Jun-hee described feeling “like a cage,” particularly during three admissions to closed wards where personal items like dolls and recording devices were prohibited, and freedom was severely restricted. He recounted instances of being admitted unexpectedly despite being told he only needed medication, leading to feelings of frustration and fear. Tenasia and The Chosun Ilbo both reported on Jun-hee’s account.

Enhanced Transparency and Whistleblower Protection

To promote fairness, the subcommittee can now reschedule reviews to allow for direct patient statements or further investigation. The regulations now include provisions to encourage whistleblowing and protect those reporting concerns. While committee members are still bound by confidentiality, exceptions are made for reports made under the Anti-Corruption and Civil Rights Commission Act or the Public Interest Reporter Protection Act.

Ministry of Health and Welfare Initiatives

The MOHW is also focused on supporting the growth of the biopharmaceutical industry through global collaboration, launching the “K-Biopharma Next Bridge” program in partnership with major pharmaceutical companies like Roche, AbbVie, and AstraZeneca. Ministry of Health and Welfare. The ministry continues to consult with partner countries on healthcare needs and tailored Official Development Assistance (ODA) cooperation. Ministry of Health and Welfare

Looking Ahead

Experts believe these revisions represent a crucial first step in safeguarding patient rights and interests. By increasing transparency, guaranteeing the right to be heard, and protecting whistleblowers, South Korea aims to ensure a more just and humane approach to hospitalization reviews.